Establishment of a Tumor Bank for Tissue Samples

Summary

Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank.

This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".

Conditions

• Ovarian Neoplasms
• Breast Neoplasms
• Colorectal Neoplasms
• Neoplasms of the Female Genitalia
• Lung Neoplasms
• Endocrine Gland Neoplasms

Interventions

OTHER

Tumor tissue collection

Tissue sample is collected during therapeutic intervention by a medical doctor/surgeon. Frozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis. Rest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.

OTHER

Sampling of ascites and pleural effusion

Samples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.

OTHER

Collecting urine samples

Patient is asked to give a urine sample. Urine is collected in urine beaker.

OTHER

Collecting saliva sample

Saliva sample is collected by spatula from the mouth cavity of the patient.

OTHER

Collecting sputum

Patient is asked to produce sputum into a 50ml lab tube.

OTHER

Collecting stool samples

Stool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.

OTHER

Lavage/Irrigation

Irrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity and fallopian tubes of women scheduled for surgery.

Sponsors & Collaborators

• Medical University of Vienna

  lead OTHER

Principal Investigators

• Robert Zeillinger, Prof.Dr. · Medical University of Vienna, Dptm. of Obstetrics & Gynaecology

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2003-09-30

Primary Completion

2026-12-31

Completion

2026-12-31

Countries

• Austria
• Belgium
• Germany

Study Locations